Myasthenia Gravis News - LARVOL Sigma

Myasthenia Gravis	Welcome, Profile Billing Logout

«1 2...31 32 33 34 353637 38 39 40 41...136 137 »

|||||||||| Journal: Astragaloside IV ameliorates experimental autoimmune myasthenia gravis by regulating CD4?+?T cells and altering gut microbiota. (Pubmed Central) - Aug 5, 2023
This study speculated that AS-IV ameliorates EAMG by regulating CD4?+?T cells and altering the structure and species of gut microbiota of EAMG.

|||||||||| Journal: Causal effect of vitamin D on myasthenia gravis: a two-sample Mendelian randomization study. (Pubmed Central) - Aug 4, 2023
Other MR methods also agreed with IVW results. This study provides the causal relationship between genetically predicted circulating vitamin D levels and MG and provides new insights into the genetics of MG.

|||||||||| Keytruda (pembrolizumab) / Merck (MSD)
MYOSITIS, MYOCARDITIS, AND MYASTHENIC CRISIS: A RARE TRIAD OF IMMUNE-RELATED ADVERSE EVENTS DUE TO PEMBROLIZUMAB THERAPY (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_5252;

|||||||||| STUNNED BY A VIRUS! - A CURIOUS CASE OF ASYMMETRIC SENSORIMOTOR AXONAL DEMYELINATING NEUROPATHY IN A PATIENT WITH WEST NILE ENCEPHALITIS (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_5200;

|||||||||| GAD-65 ANTIBODY POSITIVE DISEASE PRESENTING AS PLEURITIS, NEUROMUSCULAR WEAKNESS AND RESPIRATORY FAILURE (Convention Center 317B) - Aug 4, 2023 - Abstract #CHEST2023CHEST_4960;

|||||||||| A CASE OF LAMBERT EATON MYASTHENIC SYNDROME AND SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION AS THE INITIAL PRESENTATION OF SMALL CELL LUNG CANCER (Convention Center Exhibit Hall - Rapid Area 3C) - Aug 4, 2023 - Abstract #CHEST2023CHEST_4846;

|||||||||| Tecentriq (atezolizumab) / Roche
PREEXISTING LAMBERT EATON MYASTHENIC SYNDROME WORSENED BY ATEZOLIZUMAB IN A PATIENT WITH EXTENSIVE-STAGE SMALL-CELL LUNG CANCER: A CASE REPORT (Convention Center Exhibit Hall - Rapid Area 3C) - Aug 4, 2023 - Abstract #CHEST2023CHEST_4842;

|||||||||| HERPES SIMPLEX VIRUS TYPE 1 VIREMIA AND RAPID DETERIORATION OF AN IMMUNOCOMPROMISED PATIENT (Convention Center Exhibit Hall - Rapid Area 1A) - Aug 4, 2023 - Abstract #CHEST2023CHEST_4813;

|||||||||| BURDEN AND IMPACT OF CANCER ON OUTCOMES OF MYASTHENIA GRAVIS PATIENTS: INSIGHTS FROM NATIONAL INPATIENT SAMPLE, 2016-2019 (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_3970;
CLINICAL IMPLICATIONS: Our analysis warrants screening measures to vigilantly diagnose cancers in myasthenia gravis patients to improve survival rates. A better understanding of the pathophysiological mechanisms of Myasthenia gravis-associated cancers will enable us to predict long-term outcomes more effectively.

|||||||||| FACTORS ASSOCIATED WITH ONE-YEAR SURVIVAL AMONG PATIENTS WHO DEVELOP IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_3702;

|||||||||| fluoxetine / Generic mfg.
HIGH-DOSE FLUOXETINE DRAMATICALLY IMPROVED APNEA-HYPOPNEA INDEX IN A CASE OF CONGENITAL MYASTHENIC SYNDROME (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_3531;

|||||||||| CHEST PAIN AND PANCYTOPENIA: AN ATYPICAL PRESENTATION OF VITAMIN B12 DEFICIENCY (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_3505;

|||||||||| HYPERCAPNIC RESPIRATORY INSUFFICIENCY ASSOCIATED WITH DUAL IMMUNE CHECKPOINT INHIBITORS IN A PATIENT WITH RENAL CELL CARCINOMA (Convention Center Exhibit Hall - Rapid Area 4B) - Aug 4, 2023 - Abstract #CHEST2023CHEST_3473;

|||||||||| THE HIDDEN MENACE: WHEN A THYMOMA MASQUERADES AS A PERICARDIAL CYST (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_3452;

|||||||||| ACUTE HYPERCAPNIC RESPIRATORY FAILURE AS THE INITIAL PRESENTATION OF ANTI-RI PARANEOPLASTIC SYNDROME IN A PATIENT WITH UNDIAGNOSED BREAST CANCER (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_3448;

|||||||||| Keytruda (pembrolizumab) / Merck (MSD)
PEMBROLIZUMAB-INDUCED MYASTHENIA CRISIS, MYOCARDITIS, MYOSITIS, AND HEPATITIS (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_3432;

|||||||||| KNOW YOUR IMMUNOTHERAPY: AN UNUSUAL CASE OF HYPERCAPNIC RESPIRATORY FAILURE (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_3409;

|||||||||| A RARE CAUSE OF DIZZINESS AND GAIT ATAXIA: CLIPPERS SYNDROME (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_3142;

|||||||||| MIND THE WEAKNESS: A RARE CASE OF IMMUNE CHECKPOINT INHIBITOR-INDUCED MYASTHENIA GRAVIS (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_3034;

|||||||||| UNIQUE CASE OF SEVERE GUILLAN-BARRE SYNDROME COMPLICATED WITH SUBSEQUENT COVID-19 (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_2915;

|||||||||| LUNG TRANSPLANT IN A PATIENT WITH IPF WHO DEVELOPED MYASTHENIA GRAVIS (Convention Center Exhibit Hall - Rapid Area 4D) - Aug 4, 2023 - Abstract #CHEST2023CHEST_2892;

|||||||||| ACUTE RESPIRATORY FAILURE DUE TO IMMUNE CHECKPOINT INHIBITOR-INDUCED MYASTHENIA GRAVIS (Convention Center Exhibit Hall - Rapid Area 1B) - Aug 4, 2023 - Abstract #CHEST2023CHEST_2511;

|||||||||| OUT OF THE BLUE: A RARE CASE OF ATYPICAL GUILLAIN-BARR (Convention Center Exhibit Hall - Rapid Area 4A) - Aug 4, 2023 - Abstract #CHEST2023CHEST_2460;

|||||||||| DEVIL IN DISGUISE: A RARE PRESENTATION OF LUNG SARCOMATOID CARCINOMA MASKING AS EMPYEMA (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_2418;

|||||||||| LAMBERT EATON: A RARE PROGRESSIVE NEUROMUSCULAR DISORDER PROMPTING ICU ADMISSION (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_2417;

|||||||||| Opdivo (nivolumab) / Ono Pharma, BMS
NIVOLUMAB-INDUCED MYASTHENIA GRAVIS WITH MYOCARDITIS AND MYOSITIS (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_2411;

|||||||||| MINIMAL CHANGE DISEASE AND MYASTHENIA GRAVIS ASSOCIATED WITH THYMOMA (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_2279;

|||||||||| FROM DIPLOPIA TO DISASTER: AN INVASIVE THYMOMA WITH DROP METASTASIS PRESENTING AS MYASTHENIA CRISIS (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_2249;

|||||||||| DON???T PSILI WITH COVID! A CASE OF COVID-19 RESPIRATORY FAILURE AND MYASTHENIA GRAVIS EXACERBATION RESULTING IN PATIENT SELF-INFLICTED LUNG INJURY (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_2127;

|||||||||| DYSPHAGIA AS THE MAIN MANIFESTATION OF LATE ONSET MYASTHENIA GRAVIS: A RARE PRESENTATION (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_2110;

|||||||||| MYASTHENIA GRAVIS AS AN UNUSUAL AUTOIMMUNE COMPLICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_2104;

|||||||||| levofloxacin / Generic mfg.
AN UNUSUAL CAUSE OF MYASTHENIC CRISIS: LEVOFLOXACIN (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_2049;

|||||||||| IT IS ALL IN THE HISTORY AND PHYSICAL EXAMINATION (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1304;

|||||||||| FLIMSY DOUBLE WHAMMY: AN UNCOMMON PRESENTATION OF HYPOKALEMIC PERIODIC PARALYSIS AND MYASTHENIA GRAVIS (Convention Center Exhibit Hall) - Aug 4, 2023 - Abstract #CHEST2023CHEST_1100;

|||||||||| Journal, IO biomarker: Thymoma patients with or without myasthenia gravis have increased Th17 cells, IL-17 production and ICOS expression. (Pubmed Central) - Aug 2, 2023
Higher IL-10 and Th1 population have been observed related to thymectomy. ICOS expression and Th17 induced by thymoma may contribute to the development of TAMG.

|||||||||| Journal: Congenital myasthenic syndrome due to a genetic mutation. (Pubmed Central) - Aug 1, 2023
As a result of the patient's good compliance with treatment, he was not admitted to hospital because of respiratory distress. The lack of a unified protocol for the treatment of CMS highlights the need for a more personalized approach when dealing with patients with rare diseases.

|||||||||| Journal: Clinical Characteristics of Myasthenia Gravis Patients with COVID-19 in Guangxi, China: A Case-Control Study. (Pubmed Central) - Aug 1, 2023
MG patients with immunosuppressive drugs, younger onset, longer MG duration, or comorbidities are more susceptible to COVID-19. The baseline MG-ADL, duration of symptomatic COVID-19, GMG, and lack of COVID-19 vaccination are independent risk factors of exacerbation in MG patients with COVID-19.

|||||||||| Journal: Occurrence and severity of myasthenic crisis in an unselected Turkish cohort of patients with myasthenia gravis. (Pubmed Central) - Jul 31, 2023
Risk factors for myasthenic crisis were thymoma, older age, MuSK antibodies, and previous crises. Individualized and active immunosuppressive treatment and optimal intensive care during crises provide a good outcome for patients with generalized MG.

|||||||||| cyclosporine / Generic mfg.
Journal: Cyclosporine-induced erythromelalgia. (Pubmed Central) - Jul 31, 2023
Although exact mechanism for this rare adverse effect is unclear, it is reversible, and so clinicians should be aware of the association . Additional use of corticosteroids could aggravate cyclosporine's toxic effects.

|||||||||| Review, Journal: Myasthenia gravis. Update on diagnosis and therapy. (Pubmed Central) - Jul 31, 2023
The increase in the knowledge of the immunological components of the neuromuscular junction in the last two decades has been fundamental to identify new pathogenic antibodies, reduce the percentage of patients with seronegative myasthenia, and propose a classification of patients into subgroups with clinical-therapeutic interest. In addition, in recent years, new drugs have been developed for the treatment of patients with myasthenia gravis that are refractory to conventional immunosuppressive treatment.

|||||||||| Journal: Triple furrowed tongue in myasthenia gravis. (Pubmed Central) - Jul 31, 2023
In addition, in recent years, new drugs have been developed for the treatment of patients with myasthenia gravis that are refractory to conventional immunosuppressive treatment. No abstract available

|||||||||| Journal: Myasthenic syndrome in a patient with end-stage amyotrophic lateral sclerosis (Pubmed Central) - Jul 29, 2023
We present a case of a patient with terminal ALS and myasthenic syndrome. The main pathogenesis theories of this condition and the differential diagnosis of ALS and myasthenia gravis are discussed.

|||||||||| Role of Esophagogastroduodenoscopy in Evaluation of Progressive Neuromuscular Dysphagia (Exhibit Hall) - Jul 29, 2023 - Abstract #ACG2023ACG_3708;
Using multivariable logistic regression adjusting for male sex, age, and clinical frailty scale, ALS diagnosis (OR 0.20, 95% CI: 0.07-0.52, p=0.0011) and Neurology referral source (OR 0.37, 95% CI: 0.17-0.84, p=0.0177) were predictive of no initial EGD recommendation. ALS diagnosis was associated with gastrostomy placement (HR 10.39, 95% CI: 5.34-20.19, p< 0.0001).

|||||||||| Predictors of Percutaneous Endoscopic Gastrostomy Placement in Patients with Progressive Neuromuscular Dysphagia (Exhibit Hall) - Jul 29, 2023 - Abstract #ACG2023ACG_3707;
The most common disorders were multiple sclerosis (27.1%), myasthenia gravis (22.3%) and amyotrophic lateral sclerosis (ALS, 15.4%). A gastrostomy was recommended in 38 patients (13.9%) at the initial consultation.

|||||||||| Mesenteric Arteriovenous Malformation With Associated Inferior Mesenteric Vein Occlusion: A Rare Cause of Ischemic Colitis (Exhibit Hall) - Jul 29, 2023 - Abstract #ACG2023ACG_3569;
Figure C: Axial CT shows AVM (circle) and sigmoid colitis (arrow). Figure D: Mesenteric angiography delineating five feeding arteries into the nidus and draining vein noted in the form of large parallel superior hemorrhoidal vein and sigmoid vein.

|||||||||| A Rare Case of Localized Colonic Amyloidosis Identified During a Screening Colonoscopy (Exhibit Hall) - Jul 29, 2023 - Abstract #ACG2023ACG_2184;
Patients have a good prognosis and they do not typically transition to systemic amyloidosis. Figure: Polyp seen during colonoscopy prior to removal

|||||||||| Bouveret Syndrome: An Uncommon Cause of Small Bowel Obstruction in the Aging Population (Exhibit Hall) - Jul 29, 2023 - Abstract #ACG2023ACG_576;
Combining multiple techniques may yield better outcomes. Figure: Gallstone visualized with endoscope in duodenum bulb and duodenal bulb ulceration along with broken up stone after removal

|||||||||| Soliris (eculizumab) / AstraZeneca
P4 data, Journal, Real-world evidence, Real-world: Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan. (Pubmed Central) - Jul 29, 2023
Figure: Gallstone visualized with endoscope in duodenum bulb and duodenal bulb ulceration along with broken up stone after removal This is the largest safety dataset on eculizumab in Japan derived from more than 10

|||||||||| Preclinical, Review, Journal: An Overview of the Development and Preclinical Evaluation of Antibody-Drug Conjugates for Non-Oncological Applications. (Pubmed Central) - Jul 29, 2023
This current review focuses on the non-oncological applications of antibody-drug conjugates, their developmental studies, testing procedures, in vitro evaluations, and pre-clinical testing. Additionally, a summary of the restrictions, difficulties, and prospects for ADCs in non-oncological applications is provided.

|||||||||| Journal, HEOR: Evaluation of the Quality of Life of Patients with Myasthenia Gravis in Greece. (Pubmed Central) - Jul 29, 2023
This study is the first to report on the affected QoL of the Greek population with MG using the MG-QoL15r scale. Further work should be done to incorporate the routine evaluation of QoL in the care of patients with MG.



	Diseases Companies Products Productz Mechanisms of Action Sites